We are live on ! Find out more
BIOT

Biotech Acquisition Company Class A Ordinary Shares

Delisted

BIOT was delisted on the 2nd of February, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aristeia Capital
Connecticut
$11.3M
CCP
2
Corbin Capital Partners
New York
$9.15M
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$9.15M
Marshall Wace
4
Marshall Wace
United Kingdom
$9.03M
SCM
5
Saba Capital Management
New York
$8.92M
Citadel Advisors
6
Citadel Advisors
Florida
$8.82M -$11K -1,118 -0.1%
KC
7
Kryger Capital
United Kingdom
$8.33M +$1.69M +171,411 +25%
CM
8
Cohanzick Management
New York
$7.88M
RA
9
RiverPark Advisors
New York
$7.87M
PC
10
Periscope Capital
Ontario, Canada
$7.48M -$3.63K -369 -0%
LA
11
Linden Advisors
New York
$6.69M
FTCM
12
Fir Tree Capital Management
New York
$6.68M
Millennium Management
13
Millennium Management
New York
$5.93M +$4.61M +467,900 +351%
MI
14
MMCAP International
Cayman Islands
$5.91M -$6.69K -679 -0.1%
PAMP
15
Polar Asset Management Partners
Ontario, Canada
$5.59M -$3.76K -382 -0.1%
WCMNY
16
Westchester Capital Management (New York)
New York
$5.13M
Hudson Bay Capital Management
17
Hudson Bay Capital Management
Connecticut
$5.02M +$179K +18,159 +4%
MP
18
Mangrove Partners
Connecticut
$4.93M +$4.92M +500,000 New
AWG
19
Alpha Wave Global
New York
$4.58M
DKCM
20
Davidson Kempner Capital Management
New York
$4.43M
DCM
21
DG Capital Management
New York
$4.43M
MF
22
Magnetar Financial
Illinois
$4.13M -$114K -11,592 -3%
RCM
23
Radcliffe Capital Management
Pennsylvania
$4M
Nomura Holdings
24
Nomura Holdings
Japan
$3.94M
WAM
25
Weiss Asset Management
Massachusetts
$3.45M -$776K -78,790 -18%